Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

Research output: Contribution to journalJournal articleResearch

  • D Grint
  • L Peters
  • C Schwarze-Zander
  • M Beniowski
  • C Pradier
  • M Battegay
  • D Jevtovic
  • V Soriano
  • Lundgren, Jens
  • J K Rockstroh
  • Kirk, Ole
  • A Mocroft
  • EuroSIDA in EuroCoord
All HIV/hepatitis C virus (HCV)-coinfected patients with chronic HCV infection and ≥ F2 fibrosis should be considered for HCV therapy. This study aimed to determine the rate of HCV treatment uptake among coinfected patients in Europe.
Original languageEnglish
JournalHIV Medicine
Volume14
Issue number10
Pages (from-to)614-23
Number of pages10
ISSN1464-2662
DOIs
Publication statusPublished - Nov 2013

ID: 93934717